Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases.

Allaart, Cornelia F; Baars, Adája Elisabeth; Bekkenk, Marcel W; Bemelman, Frederique J; Boekel, Laura; Bosma, Angela L; Broens, Bo; Brusse, Esther; Busch, Matthias H; Cristianawati, Olvi; D'Haens, Geert R A M; de Leeuw, Karina; Eftimov, Filip; Goedee, H Stephan; Hijnen, Dirkjan; Hilhorst, Marc L; Horváth, Barbara; Jallah, Papay B P; Keijser, Jim; Keijzer, Sofie; Killestein, Joep; Kuijpers, Taco W; Kummer, Laura Y; Löwenberg, Mark; Musters, Annelie H; Parra Sanchez, Agner; Post, Nicoline F; Raaphorst, Joost; Rispens, Theo; Ruiter, Annabel M; Rutgers, Abraham; Schreurs, Corine R G; Spuls, Phyllis I; Stalman, Eileen W; Steenhuis, Maurice; Takkenberg, Bart; Tas, Sander W; Ten Brinke, Anja; Teng, Y K Onno; van Dam, P J Koos; Van der Kooi, Anneke; van der Pol, W Ludo; van der Woude, Diane; van Doorn, Pieter A; van Els, Cécile A C M; van Ham, S Marieke; van Kempen, Zoe L E; van Ouwerkerk, Lotte; van Paassen, Pieter; Vegting, Yosta; Verschuuren, Jan J G M; Verstegen, Niels J M; Volkers, Adriaan G; Voskuyl, Alexandre; Wieske, Luuk; Wit, Jelle De; Wolbink, Gertjan; Zwinderman, Koos A H

Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases.

Authors: Cornelia F Allaart
Adája Elisabeth Baars
Marcel W Bekkenk
Frederique J Bemelman
Laura Boekel
Angela L Bosma
Bo Broens
Esther Brusse
Matthias H Busch
Olvi Cristianawati
Geert R A M D'Haens
Karina de Leeuw
Filip Eftimov
H Stephan Goedee
Dirkjan Hijnen
Marc L Hilhorst
Barbara Horváth
Papay B P Jallah
Jim Keijser
Sofie Keijzer
Joep Killestein
Taco W Kuijpers
Laura Y Kummer
Mark Löwenberg
Annelie H Musters
Agner Parra Sanchez
Nicoline F Post
Joost Raaphorst
Theo Rispens
Annabel M Ruiter
Abraham Rutgers
Corine R G Schreurs
Phyllis I Spuls
Eileen W Stalman
Maurice Steenhuis
Bart Takkenberg
Sander W Tas
Anja Ten Brinke
Y K Onno Teng
P J Koos van Dam
Anneke Van der Kooi
W Ludo van der Pol
Diane van der Woude
Pieter A van Doorn
Cécile A C M van Els
S Marieke van Ham
Zoe L E van Kempen
Lotte van Ouwerkerk
Pieter van Paassen
Yosta Vegting
Jan J G M Verschuuren
Niels J M Verstegen
Adriaan G Volkers
Alexandre Voskuyl
Luuk Wieske
Jelle De Wit
Gertjan Wolbink
Koos A H Zwinderman
Publication date: 1 January 2023
Publisher: 'BMJ'
Doi

Abstract

Patients with immune-mediated inflammatory diseases (IMIDs) may have impaired initial humoral responses after SARS-CoV-2 vaccination depending on the type of immunosuppression (ISP) used.1 It is largely unknown how antibody titres develop over time and whether it is needed to adjust timing of booster campaigns for patients with IMID